Skip to content

Neurolutions Upper Extremity Rehabilitation System

by Neurolutions, Inc

De Novo DEN200046

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 9 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 9 Oct 2026. What this means

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN200046 Date23 Apr 2021DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 9 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
QOL
FDA applicant
Neurolutions, Inc.
Device Class
Class II
Regulation
21 CFR Part 890.5420
Advisory Committee
Neurology
FDA Decision
DENG De Novo granted

Other devices from Neurolutions, Inc